VTA1P2

Across TCGA patient cohorts, VTA1P2 RNA expression is significantly associated with the go_rna of many other GO terms, with 3,083 significant associations in total. STAD shows the largest number of these associations.

The most reproducible VTA1P2-associated GO terms across cancer lineages are RNA modification, Peptidyl-lysine modification, and Nucleus organization. Each is linked with VTA1P2 in more than 5 cancer types. Because this analysis shows association rather than direction, both VTA1P2-to-partner and partner-to-VTA1P2 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, RNA modification grouped by VTA1P2-low versus VTA1P2-high in STAD.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (VTA1P2→partner) and Y-score (partner→VTA1P2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
STAD	RNA modification →	+0.089	+0.064	<.001	.004	3	6
STAD	Peptidyl-lysine modification →	+0.086	+0.058	<.001	.002	3	5
STAD	Nucleus organization →	+0.099	+0.064	<.001	.001	3	5
STAD	Positive regulation of telomerase RNA localization to Cajal body →	+0.111	+0.070	<.001	.008	3	5
STAD	Transcription by RNA polymerase I →	+0.101	+0.059	<.001	.001	3	5
STAD	snRNA metabolic process →	+0.092	+0.040	<.001	.002	3	5

Each partner links to its Q-omics profile. Showing the 6 strongest of 3,083 associations by consensus.

RNA modification by VTA1P2 expression — STAD

Explore this box plot interactively →